Literature DB >> 10367372

Angiomyolipoma of the kidney and lymph nodes.

T Fröhlich1, A Brands, W F Thon, H P Weskott, H Ostertag.   

Abstract

Angiomyolipoma (AML) is a benign mesenchymal tumor predominantly occurring in the kidney. Despite its low incidence of 0.07-0.03% in an unselected population, this tumor is well known, because the typical AML can be diagnosed without histological confirmation by a combination of ultrasound (US) and computerized tomography (CT) imaging in up to 95% of cases. In contrast, simultaneous involvement of the kidney and the regional lymph nodes is less known and might be confused with metastasizing malignant tumor. We report a case of the very uncommon simultaneous involvement of the kidney and the lymph nodes in AML.

Entities:  

Mesh:

Year:  1999        PMID: 10367372     DOI: 10.1007/s003450050117

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  5 in total

Review 1.  Management of incidental renal masses: Time to consider contrast-enhanced ultrasonography.

Authors:  Francesca Di Vece; Paola Tombesi; Francesca Ermili; Sergio Sartori
Journal:  Ultrasound       Date:  2016-01-14

2.  Perivascular epithelioid cell neoplasm of the colon.

Authors:  Hugh James Freeman; Doug L Webber
Journal:  World J Gastrointest Oncol       Date:  2010-04-15

3.  Contrast enhanced ultrasound of renal masses.

Authors:  Andre Ignee; Bernd Straub; Gudrun Schuessler; Christoph Frank Dietrich
Journal:  World J Radiol       Date:  2010-01-28

4.  Minimal fat renal angiomyolipoma with lymph node involvement: A case report and literature review.

Authors:  Guangxiang Liu; Dongwei Yao; Shiwei Zhang; Xiaozhi Zhao; Tieshi Liu; Xiaogong Li; Hongqian Guo
Journal:  Can Urol Assoc J       Date:  2015-08-10       Impact factor: 1.862

5.  A 22-year-old female with invasive epithelioid angiomyolipoma and tumor thrombus into the inferior vena cava: case report and literature review.

Authors:  Campbell Grant; John M Lacy; Stephen E Strup
Journal:  Case Rep Urol       Date:  2013-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.